Private Label CBD Gummies Market Set to Surpass USD 1.38 Billion by 2036
According to Future Market Insights (FMI), the private label CBD gummies market was valued at USD 598.9 million in 2025 and is expected to reach USD 646.2 million in 2026. Between 2026 and 2036, the market is projected to expand to USD 1,382.2 million, reflecting a compound annual growth rate (CAGR) of 7.9 % over the forecast period.
The growth is driven by wellness brands opting for outsourced manufacturing, a surge in demand for ready‑to‑market CBD edibles, and the increasing popularity of white‑label production models that lower launch costs and accelerate time‑to‑market.
Why Wellness Brands Are Turning to Private Label Solutions
Rather than building extraction or confectionery facilities, many brands partner with experienced contract manufacturers. These partners provide formulation expertise, packaging support, quality testing, and regulatory documentation under private or white‑label agreements.
Three primary factors are fueling this shift:
- Wellness brands seek to reduce capital investment and speed up product launches.
- Suppliers are expanding formulation, testing, packaging, and compliance support to help brands navigate evolving CBD regulations.
- Direct‑to‑consumer sales via brand websites continue to improve customer education, encourage subscription‑based purchases, and drive repeat sales.
Nandini Roy Choudhury, Principal Consultant for Food & Beverage at FMI, notes:
“Private label CBD gummies provide wellness brands with a faster and more efficient route into the expanding CBD edibles market. Going forward, competitive advantage will increasingly depend on suppliers that combine formulation expertise with comprehensive testing, compliant labeling, and retail‑ready documentation, enabling brands to scale confidently while meeting evolving regulatory expectations.”
Service Model: White Label Gummies Lead the Market
In 2026, white label gummies accounted for 46.2 % of global demand, making them the leading service model. Their appeal lies in shorter commercialization timelines, lower formulation costs, established manufacturing processes, and simplified packaging solutions that enable new wellness brands to enter the market quickly.
By leveraging existing formulations and production capabilities, white label manufacturers allow companies to focus on branding, marketing, and customer acquisition rather than product development and infrastructure.
Supporting Points
- White label gummies represent 46.2 % of the market share in 2026.
- Ready‑made formulations significantly reduce product development timelines.
- Contract manufacturing continues to support the rapid expansion of startup wellness brands.
- Co‑packing and bulk gummy services remain attractive for companies seeking customized packaging and scalable production.
CBD Spectrum Preferences: Broad‑Spectrum Takes the Lead
Broad‑spectrum CBD gummies captured 42.8 % of market demand in 2026, driven by consumer preference for THC‑free wellness products that still retain multiple naturally occurring cannabinoids.
This positioning improves retail acceptance and consumer confidence, while full‑spectrum products continue to serve experienced users seeking entourage‑effect formulations. CBD isolate and minor cannabinoid blends remain important for specialized portfolios.
Supporting Points
- Broad‑spectrum CBD gummies represent 42.8 % of the market share in 2026.
- THC‑free positioning improves retail acceptance and consumer confidence.
- Full‑spectrum products continue serving experienced CBD consumers seeking entourage‑effect formulations.
- CBD isolate and minor cannabinoid blends remain important for specialized product portfolios.
Sales Channels: Brand Websites Dominate
Brand websites accounted for 39.6 % of global sales channel demand in 2026, making them the leading distribution route. Direct‑to‑consumer platforms give manufacturers greater control over customer education, product positioning, subscription programs, and repeat purchasing.
Unlike traditional retail, these digital channels allow brands to communicate dosage guidance, laboratory testing information, ingredient sourcing, and quality certifications before purchase. They also provide flexibility for updating compliance information as regulatory scrutiny increases.
Supporting Points
- Brand websites represent 39.6 % of global sales channel demand in 2026.
- Direct‑to‑consumer platforms strengthen customer engagement and subscription‑based purchasing.
- Specialist wellness retailers remain important for premium CBD product positioning.
- Pharmacy‑style retail and licensed cannabis outlets continue supporting compliant product distribution where regulations permit.
Market Dynamics: Drivers, Restraints, and Trends
Drivers
Growing demand for outsourced manufacturing and faster product commercialization is accelerating the adoption of private label CBD gummies worldwide. Wellness brands are increasingly partnering with experienced manufacturers to reduce capital investment, shorten product development cycles, and launch differentiated CBD products with greater speed. Rising consumer preference for convenient edible formats, clean‑label ingredients, and THC‑free formulations further supports market expansion.
Restraints
Despite strong growth prospects, the market faces regulatory complexity surrounding CBD health claims, labeling requirements, cannabinoid content verification, and product safety documentation. Variations in CBD regulations across countries can delay commercialization, increase compliance costs, and limit retail expansion for emerging brands.
Trends
The industry is witnessing growing investment in:
- White label manufacturing solutions for faster brand launches
- Broad‑spectrum and THC‑free CBD formulations
- Customized gummy formulations targeting sleep, relaxation, and daily wellness
- Third‑party laboratory testing and enhanced batch traceability
- Sustainable packaging and clean‑label product development
- Subscription‑based direct‑to‑consumer business models
- Digital customer education focused on dosage, safety, and product transparency
Geographic Outlook: Fastest‑Growing Countries
North America continues to dominate the global market, supported by a mature CBD ecosystem, expanding direct‑to‑consumer brands, and well‑established contract manufacturing capabilities. Europe is experiencing steady growth as regulatory frameworks become clearer, while Australia benefits from increasing medical cannabis awareness.
Projected CAGR through 2036:
- United States: 8.5 %
- Canada: 8.1 %
- United Kingdom: 7.8 %
- Germany: 7.5 %
- Australia: 7.3 %
- Netherlands: 6.9 %
- France: 6.4 %
The United States remains the fastest‑growing market due to its strong direct‑to‑consumer infrastructure, expanding wellness startup ecosystem, and broad availability of private label manufacturing services.
Key Players in the Private Label CBD Gummies Market
Competition centers on formulation expertise, manufacturing scalability, compliance support, cannabinoid testing, packaging capabilities, and private label service offerings. Companies that provide comprehensive production, documentation, and regulatory assistance are strengthening their competitive position as wellness brands seek reliable outsourcing partners.
Major companies operating in the market include:
- CBD Nationwide — Private label manufacturing and formulation support
- Extract Labs — CBD extraction, formulation, and customized manufacturing
- cbdMD, Inc. — Consumer CBD product development and gummy portfolio
- Charlotte’s Web Holdings, Inc. — Premium hemp‑derived wellness products
- CV Sciences, Inc. — Science‑backed CBD nutrition solutions
- Medterra CBD LLC — Broad‑spectrum CBD product portfolio
- British Cannabis — European CBD manufacturing and private label services
- Cannaray Limited — CBD wellness products and specialist retail
- MediPharm Labs Corp. — Pharmaceutical‑grade cannabinoid manufacturing
- Little Green Pharma Ltd. — Medical cannabis and CBD manufacturing solutions
Frequently Asked Questions
What is the size of the Private Label CBD Gummies Market in 2026?
The Private Label CBD Gummies Market is valued at USD 646.2 million in 2026.
What is the projected market value by 2036?
The market is expected to reach USD 1,382.2 million by 2036.
What is the CAGR of the Private Label CBD Gummies Market from 2026 to 2036?
The market is forecast to expand at a 7.9 % CAGR during the forecast period.
Which service model dominates the market?
White Label Gummies lead the market, accounting for 46.2 % of global demand in 2026.
Which CBD spectrum holds the largest market share?
Broad‑Spectrum CBD Gummies dominate the market with a 42.8 % share in 2026.
Which sales channel leads the market?
Brand Websites remain the leading sales channel, representing 39.6 % of global demand in 2026.
Which country is projected to grow the fastest?
The United States is expected to be the fastest‑growing market, registering a CAGR of 8.5 % through 2036.
Explore Related Analysis
For additional insights, visit the following resources:
About Future Market Insights (FMI)
Future Market Insights (FMI) delivers actionable, decision‑focused market intelligence that goes beyond traditional research reports. The company provides:
- In‑depth pricing and cost benchmarking analysis
- Demand forecasting based on real industry inputs
- Procurement and buyer behavior insights
- Supply chain and trade flow intelligence
- Technology adoption trends across industries
FMI follows a robust bottom‑up research methodology, combining insights from industry experts, procurement leaders, and technical professionals to ensure accurate and practical market intelligence.
For the original press release, see: Here
